- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04969133
TAP Block Versus Local Anesthesia Wound Infiltration for Postoperative Pain Relief After Appendicectomy in Children (PABLO)
TAP Block Versus Local Anesthesia Infiltration at Wound Site for Postoperative Pain Relief After Laparoscopic Appendicectomy in Children
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Amélie JURINE, Doctor
- Phone Number: 0033381669403
- Email: ajurine@chu-besancon.fr
Study Locations
-
-
-
Besançon, France, 25000
- Recruiting
- CHU Besançon
-
Contact:
- Amélie JURINE, Doctor
- Phone Number: +33381669403
- Email: ajurine@chu-besancon.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age betwween 3 and 15 years
- Weight < or = 50 kg
- indicaction of coelioscopic appendicectomy
- ASA 1,2 or 3
- consent of the children and the holder of parental autority
Exclusion Criteria:
- Age<3 years or > 15years or weight > 50kg
- refusal of the children and the holder of parental autority
- ASA 4
- Peritonitis
- Patients with long term morphinic traitment
- Epilepsy
- Hepato-cellular insuffisiancy
- local anesthesia allergy or nalbuphine allergy
- coagulation abnomrmality
- exclusion of health insurance
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: TAP Block
Transverse abdominal block is realisated at the beginning of the surgery with ultrasound guided technique with levobupivacaine 2.5mg/mL, 0.3mL/kg each side. The patient receives usual analgesia protocol. |
To compare TAP block versus local infiltration of the trocar wounds with levobupivacaine 2.5 mg/ml for post operative pain relief after laparoscopic appendicectomy in children
|
Active Comparator: local infiltration of the trocar wounds
local infiltration of the trocar wounds is realisated at the end of the surgery by the surgeon with levobupivacaine 2.5mg/mL 0.6mL/kg distributed in each trocar opening. The patient receives usual analgesia protocol. |
To compare TAP block versus local infiltration of the trocar wounds with levobupivacaine 2.5 mg/ml for post operative pain relief after laparoscopic appendicectomy in children
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
cumulative dose of nalbuphine in the 24 first hours post surgery
Time Frame: 24 hours
|
recording in mg/kg
|
24 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
cumulative dose of nalbuphine H0-H12 post surgery
Time Frame: from beginning to 12th hour
|
recording in mg/kg
|
from beginning to 12th hour
|
cumulative dose of nalbuphine H13-H24 post surgery
Time Frame: From 13th hour to 24th hour
|
recording in mg/kg
|
From 13th hour to 24th hour
|
FLACC analgesia score at H1 H2 H6 H12 H24
Time Frame: FLACC score will be performed from awakenig to 24 hours post surgery
|
Face Leg Activity Cry Consolability heteroevaluation scale from 0 to 10
|
FLACC score will be performed from awakenig to 24 hours post surgery
|
FLACC score mean
Time Frame: FLACC score will be performed from awakenig to 24 hours surgery
|
Face Leg Activity Cry Consolability heteroevaluation scale from 0 to 10
|
FLACC score will be performed from awakenig to 24 hours surgery
|
individual variations of FLACC score
Time Frame: FLACC score will be performed from awakenig to 24 hours surgery
|
Face Leg Activity Cry Consolability heteroevaluation scale from 0 to 10
|
FLACC score will be performed from awakenig to 24 hours surgery
|
timing of first injection of nalbuphine
Time Frame: in the first 24 post operative hours
|
recording date and time of first injection
|
in the first 24 post operative hours
|
incidence of post operative nausea and vomiting
Time Frame: in the first 24 post operative hours
|
recording the incidence post operative nausea and vomiting
|
in the first 24 post operative hours
|
timing of first standing up
Time Frame: in the first 24 post operative hours
|
recording date and time of first standing up
|
in the first 24 post operative hours
|
adverse events
Time Frame: in the first 24 post operative hours
|
adverse event monitoring
|
in the first 24 post operative hours
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Digestive System Diseases
- Pathologic Processes
- Infections
- Postoperative Complications
- Pain
- Neurologic Manifestations
- Gastrointestinal Diseases
- Gastroenteritis
- Intestinal Diseases
- Cecal Diseases
- Intraabdominal Infections
- Pain, Postoperative
- Appendicitis
- Physiological Effects of Drugs
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Sensory System Agents
- Anesthetics
- Anesthetics, Local
- Levobupivacaine
Other Study ID Numbers
- 2021/571
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Analgesia
-
Mansoura UniversityNot yet recruiting
-
Southeast University, ChinaRecruiting
-
Medical University of South CarolinaRecruiting
-
Southeast University, ChinaRecruiting
-
Huazhong University of Science and TechnologyRecruiting
-
Mansoura UniversityCompleted
-
University of FloridaMdoloris Medical SystemsCompletedAnalgesiaUnited States
-
Mansoura UniversityCompleted
-
Cessatech A/SCompleted
-
Kalyra Pharmaceuticals, Inc.United States Department of Defense; PRA Health SciencesTerminated
Clinical Trials on Levobupivacaine Hydrochloride 2.5 MG/ML
-
Ain Shams UniversityCompletedPain After Knee ArthroscopEgypt
-
Instituto de Investigación Sanitaria AragónHospital Miguel ServetCompletedBrachial Plexus Block | Diaphragmatic ParalysisSpain
-
Suzhou Kintor Pharmaceutical Inc,Completed
-
Pontificia Universidad Catolica de ChileUnknown
-
Gazi UniversityCompletedDrug Effect | Anesthesia | General Surgery | Outpatients | Anorectal Disorder
-
University of PatrasCompletedPostoperative Pain | Morbid Obesity | Postoperative Bowel Function | Postoperative AmbulationGreece
-
Biozeus Biopharmaceutical S.A.Not yet recruitingFemale Sexual Dysfunction | Female Sexual Arousal Disorder
-
AstraZenecaTerminatedPlaque Psoriasis VulgarisDenmark
-
Columbia UniversityUniversity of MinnesotaTerminated
-
University of PatrasUnknownStillborn Caesarean SectionGreece